Harbour Investments’s Cellectis CLLS Stock Holding History

Harbour Investments’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.3K	Hold	4,500	–	–	﹤0.01%	3081
2025 Q4	$21.8K	Hold	4,500	–	–	﹤0.01%	2383
2025 Q3	$12.8K	Hold	4,500	–	–	﹤0.01%	2564
2025 Q2	$6.86K	Hold	4,500	–	–	﹤0.01%	2736
2025 Q1	$5.58K	Hold	4,500	–	–	﹤0.01%	2781
2024 Q4	$8.1K	Sell	4,500 -1,600	-26%	-$2.98K	﹤0.01%	2541
2024 Q3	$12.9K	Hold	6,100	–	–	﹤0.01%	2245
2024 Q2	$11.4K	Hold	6,100	–	–	﹤0.01%	2196
2024 Q1	$16.2K	Buy	+6,100	New	+$16.9K	﹤0.01%	2047
2021 Q4	–	Sell	-1,646	Closed	-$21K	–	2801
2021 Q3	$21K	Buy	1,646 +379	+30%	+$5.25K	﹤0.01%	2262
2021 Q2	$20K	Sell	1,267 -781	-38%	-$13.1K	﹤0.01%	2337
2021 Q1	$41K	Buy	+2,048	New	+$50.6K	﹤0.01%	1799

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Harbour Investments's CLLS Position: Q1 2026 in Review

Harbour Investments held its Cellectis (CLLS) position steady in Q1 2026 at 4,500 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3081.

Harbour Investments first reported a position in CLLS in Q1 2021 and has held it in 12 quarters since. The position peaked at $41K in Q1 2021. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.

Harbour Investments held 4,500 shares of Cellectis worth $14.3K as of Q1 2026.
Harbour Investments left its Cellectis share count unchanged in Q1 2026.
Cellectis made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3081 holding.
Harbour Investments first reported a position in Cellectis in Q1 2021 and has held it in 12 quarters since.
Harbour Investments's Cellectis position peaked at $41K in Q1 2021.
32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.